Tumor Angiogenesis Therapy Using Targeted Delivery of Paclitaxel to the Vasculature of Breast Cancer Metastases

Table 1

PTX-FFRck-fVIIa as a competitive inhibitor of factor VIIa.

Factor VIIa activity	Clotting time (in sec.)	% inhibition of fVIIa activity
fVIIa	14.3	0
PTX-FFRck-fVIIa	37.5	93.2